Insider Trading Activity For Exact Sciences Corporation (NASDAQ:EXAS)
Thomas D Carey , Director of Exact Sciences Corporation (NASDAQ:EXAS) reportedly Bought 2,500 shares of the company’s stock at an average price of 37.71 for a total transaction amount of $94,275.00 SEC Form
Insider Trading History For Exact Sciences Corporation (NASDAQ:EXAS)
Analyst Ratings For Exact Sciences Corporation (NASDAQ:EXAS)
These are 3 Hold Ratings, 10 Buy Ratings .
The current consensus rating for Exact Sciences Corporation (NASDAQ:EXAS) is Buy (Score: 2.77) with a consensus target price of $40.77 , a potential (7.66% upside)
Analyst Ratings History For Exact Sciences Corporation (NASDAQ:EXAS)
- with a price target of $7.00 to $6.50
- On 7/15/2016 William Blair Reiterated Rating Outperform with a price target of $29.00
- On 7/27/2016 Mizuho Boost Price Target of rating Neutral with a price target of $10.00 to $15.00
- On 4/28/2017 Leerink Swann Set Price Target of rating Buy with a price target of $38.00
- On 5/1/2017 Goldman Sachs Group, Inc. (The) Set Price Target of rating Neutral with a price target of $21.00 to $33.00
- On 5/31/2017 Cowen and Company Reiterated Rating Outperform with a price target of $45.00
- On 6/1/2017 Jefferies Group LLC Set Price Target of rating Buy with a price target of $35.00
Recent Trading Activity for Exact Sciences Corporation (NASDAQ:EXAS)
Shares of Exact Sciences Corporation closed the previous trading session at 37.87 up +0.41 1.09% with 1,039,106 shares trading hands.